Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Irene Hernandez-Martin
Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Severe Eosinophilic Asthma and Aspirin-Exacerbated Respiratory Disease Associated to Eosinophilic Gastroenteritis Treated With Mepolizumab: A Case Report
Allergy, Asthma and Clinical Immunology
Immunology
Pulmonary
Allergy
Respiratory Medicine
Mepolizumab for Severe Refractory Eosinophilic Asthma: Evidence to Date and Clinical Potential
Therapeutic Advances in Chronic Disease
Medicine
Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
